Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Immune-related Adverse Events of Pembrolizumab in a Large Real-world Cohort of Patients With NSCLC With a PD-L1 Expression ≥ 50% and Their Relationship With Clinical Outcomes.
Cortellini A, Friedlaender A, Banna GL, Porzio G, Bersanelli M, Cappuzzo F, Aerts JGJV, Giusti R, Bria E, Cortinovis D, Grossi F, Migliorino MR, Galetta D, Passiglia F, Berardi R, Mazzoni F, Di Noia V, Signorelli D, Tuzi A, Gelibter A, Marchetti P, Macerelli M, Rastelli F, Chiari R, Rocco D, Inno A, Di Marino P, Mansueto G, Zoratto F, Santoni M, Tudini M, Ghidini M, Filetti M, Catino A, Pizzutilo P, Sala L, Occhipinti MA, Citarella F, Russano M, Torniai M, Cantini L, Follador A, Sforza V, Nigro O, Ferrara MG, D'Argento E, Leonetti A, Pettoruti L, Antonuzzo L, Scodes S, Landi L, Guaitoli G, Baldessari C, Bertolini F, Della Gravara L, Dal Bello MG, Belderbos RA, De Filippis M, Cecchi C, Ricciardi S, Donisi C, De Toma A, Proto C, Addeo A, Cantale O, Ricciuti B, Genova C, Morabito A, Santini D, Ficorella C, Cannita K. Cortellini A, et al. Among authors: cannita k. Clin Lung Cancer. 2020 Nov;21(6):498-508.e2. doi: 10.1016/j.cllc.2020.06.010. Epub 2020 Jun 21. Clin Lung Cancer. 2020. PMID: 32680806
[The adjuvant therapy of colonic carcinoma in old age].
Ficorella C, Cannita K, Ricevuto E, Porzio G, Trapasso T, De Galitiis F, Gallà DA, Morese R, D'Addario M, Marchetti P. Ficorella C, et al. Among authors: cannita k. Minerva Med. 1999 Jul-Aug;90(7-8):232-3. Minerva Med. 1999. PMID: 10719426 Italian. No abstract available.
[Oxaliplatin: preclinical in vitro studies].
Marchetti P, Carlo G, Cappellini A, Porzio G, Ricevuto E, Cannita K, Ficorella C. Marchetti P, et al. Among authors: cannita k. Tumori. 2001 Nov-Dec;87(6):A22-4. Tumori. 2001. PMID: 11995699 Review. Italian. No abstract available.
[Familiarity and heredity of tumors in function of an early surgical therapeutic approach].
Ricevuto E, Di Rocco ZC, Cianci G, Bisegna R, Casilli F, De Galitiis F, Cannita K, Calista F, Porzio G, Bafile A, Vicentini R, Resta V, De Rubeis G, Martinotti S, Ficorella C, Marchetti P. Ricevuto E, et al. Among authors: cannita k. Suppl Tumori. 2002 May-Jun;1(3):S89-91. Suppl Tumori. 2002. PMID: 12415797 Review. Italian. No abstract available.
Prognostic value of p53 molecular status in high-risk primary breast cancer.
Marchetti P, Cannita K, Ricevuto E, De Galitiis F, Di Rocco ZC, Tessitore A, Bisegna R, Porzio G, De Rubeis GP, Ventura T, Martinotti S, Ficorella C. Marchetti P, et al. Among authors: cannita k. Ann Oncol. 2003 May;14(5):704-8. doi: 10.1093/annonc/mdg197. Ann Oncol. 2003. PMID: 12702523 Free article.
Timed flat infusion of 5-fluorouracil increases the tolerability of 5-fluorouracil/docetaxel regimen in metastatic breast cancer: a dose-finding study.
Ficorella C, Morelli MF, Ricevuto E, Cannita K, Porzio G, Baldi PL, Cianci G, DI Rocco ZC, Natoli C, Tinari N, DE Galitiis F, Calista F, Marchetti P. Ficorella C, et al. Among authors: cannita k. Br J Cancer. 2004 Aug 16;91(4):618-20. doi: 10.1038/sj.bjc.6601971. Br J Cancer. 2004. PMID: 15292944 Free PMC article. Clinical Trial.
104 results